Plain-English translation of NCT07172386 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing a three-part treatment approach for advanced kidney cancer: a procedure to block blood vessels feeding the tumor, followed by two medications called . The goal is to shrink the tumor and make surgery safer and more effective before patients have their kidney removed.
Advanced kidney cancer is hard to treat and surgery alone may not be enough. Doctors want to see if giving treatment before surgery—rather than after—can help patients have better outcomes and make their operations go more smoothly.
You likely qualify if…
You likely don't qualify if…
You would first have a procedure to block the blood vessels feeding your tumor. One week later, you would begin taking two medications: one injection every three weeks and one pill daily, for about a month. After surgery to remove your kidney, you would continue taking the medications for up to a year. Throughout the trial, you'll have regular blood tests, imaging scans, and doctor visits to monitor how well the treatment is working and to check for side effects.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
China